Karen Nuytemans

2.6k total citations
33 papers, 877 citations indexed

About

Karen Nuytemans is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Karen Nuytemans has authored 33 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 12 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Karen Nuytemans's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological diseases and metabolism (6 papers) and Genetic Associations and Epidemiology (5 papers). Karen Nuytemans is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological diseases and metabolism (6 papers) and Genetic Associations and Epidemiology (5 papers). Karen Nuytemans collaborates with scholars based in United States, Belgium and France. Karen Nuytemans's co-authors include Jessie Theuns, Christine Van Broeckhoven, Marc Cruts, Jeffery M. Vance, Eden R. Martin, Sebastiaan Engelborghs, William K. Scott, Patrick Cras, Barbara Pickut and Ellen Corsmit and has published in prestigious journals such as Neurology, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Karen Nuytemans

31 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Nuytemans United States 13 570 347 277 217 159 33 877
Mohamad Saad Egypt 5 477 0.8× 247 0.7× 212 0.8× 216 1.0× 155 1.0× 7 706
Lasse Pihlstrøm Norway 18 549 1.0× 310 0.9× 284 1.0× 229 1.1× 222 1.4× 49 904
Eleanna Kara United Kingdom 17 729 1.3× 322 0.9× 406 1.5× 259 1.2× 352 2.2× 25 1.1k
Fabrizio Pontarelli United States 12 379 0.7× 514 1.5× 410 1.5× 183 0.8× 142 0.9× 17 1.1k
Shabnam Salehi‐Rad Canada 11 457 0.8× 249 0.7× 211 0.8× 164 0.8× 217 1.4× 13 660
Xinling Yang China 14 273 0.5× 313 0.9× 154 0.6× 201 0.9× 111 0.7× 67 784
Marta Blázquez Estrada Spain 14 398 0.7× 283 0.8× 197 0.7× 168 0.8× 118 0.7× 42 654
Gye Sun Jeon South Korea 18 250 0.4× 506 1.5× 241 0.9× 129 0.6× 145 0.9× 47 891
Ammar F. Mubaidin Jordan 4 605 1.1× 395 1.1× 293 1.1× 246 1.1× 275 1.7× 7 1.1k
Jonathan C. Grima United States 10 406 0.7× 517 1.5× 186 0.7× 108 0.5× 178 1.1× 10 903

Countries citing papers authored by Karen Nuytemans

Since Specialization
Citations

This map shows the geographic impact of Karen Nuytemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Nuytemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Nuytemans more than expected).

Fields of papers citing papers by Karen Nuytemans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Nuytemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Nuytemans. The network helps show where Karen Nuytemans may publish in the future.

Co-authorship network of co-authors of Karen Nuytemans

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Nuytemans. A scholar is included among the top collaborators of Karen Nuytemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Nuytemans. Karen Nuytemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nuytemans, Karen, et al.. (2023). Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease. Pharmaceuticals. 16(6). 883–883. 14 indexed citations
2.
Gao, Xiaoyi, Ke Qin, Karen Nuytemans, et al.. (2023). Explainable machine learning aggregates polygenic risk scores and electronic health records for Alzheimer’s disease prediction. Scientific Reports. 13(1). 450–450. 20 indexed citations
3.
4.
Oron, Oded, Maria Tereza Cartaxo Muniz, Farid Rajabli, et al.. (2022). Using Oligodendrocytes for studies in Alzheimer disease. Alzheimer s & Dementia. 18(S3).
5.
Nuytemans, Karen, Liyong Wang, Jeffery M. Vance, et al.. (2021). Derivation of stem cell line UMi028-A-2 containing a CRISPR/Cas9 induced Alzheimer’s disease risk variant p.S1038C in the TTC3 gene. Stem Cell Research. 52. 102258–102258. 7 indexed citations
6.
Small, Kent W., Karen Nuytemans, Andrea L. Vincent, et al.. (2021). A novel duplication involving PRDM13 in a Turkish family supports its role in North Carolina macular dystrophy (NCMD/MCDR1).. PubMed. 27. 518–527. 4 indexed citations
7.
Nuytemans, Karen, Farid Rajabli, Parker L. Bussies, et al.. (2020). Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin. Frontiers in Neurology. 11. 573733–573733. 6 indexed citations
8.
Nuytemans, Karen, Clara P. Manrique, William K. Scott, et al.. (2019). Motivations for Participation in Parkinson Disease Genetic Research Among Hispanics versus Non-Hispanics. Frontiers in Genetics. 10. 658–658. 12 indexed citations
9.
Nuytemans, Karen, Thomas L. Ortel, Lissette Gomez, et al.. (2017). Variants in chondroitin sulfate metabolism genes in thrombotic storm. Thrombosis Research. 161. 43–51. 5 indexed citations
10.
Nuytemans, Karen, David A. Davis, William K. Scott, et al.. (2016). Generation of disease-specific autopsy-confirmed iPSCs lines from postmortem isolated Peripheral Blood Mononuclear Cells. Neuroscience Letters. 637. 201–206. 5 indexed citations
11.
Nuytemans, Karen, Gary W. Beecham, Liyong Wang, et al.. (2014). Absence of C9ORF72 expanded or intermediate repeats in autopsy‐confirmed Parkinson's disease. Movement Disorders. 29(6). 827–830. 18 indexed citations
12.
Nuytemans, Karen, Gary W. Beecham, Liyong Wang, et al.. (2014). Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. 1 indexed citations
13.
Nuytemans, Karen, Güney Bademci, Amy Dressen, et al.. (2013). Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. Neurology. 80(11). 982–989. 48 indexed citations
14.
Theuns, Jessie, David Crosiers, Luc Debaene, et al.. (2012). Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa‐responsive dystonia. Movement Disorders. 27(11). 1451–1456. 8 indexed citations
15.
Meeus, Bram, Aline Verstraeten, Karen Nuytemans, et al.. (2010). Dementia with Lewy Bodies: A Role for Dementia and Parkinson's Disease Genes?. Movement Disorders. 25. 1 indexed citations
16.
Meeus, Bram, Karen Nuytemans, David Crosiers, et al.. (2010). Comprehensive Genetic and Mutation Analysis of Familial Dementia with Lewy Bodies Linked to 2q35-q36. Journal of Alzheimer s Disease. 20(1). 197–205. 9 indexed citations
17.
Nuytemans, Karen, Jessie Theuns, Marc Cruts, & Christine Van Broeckhoven. (2010). Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Human Mutation. 31(7). 763–780. 398 indexed citations
18.
Meeus, Bram, Karen Nuytemans, David Crosiers, et al.. (2009). GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population. Neurobiology of Aging. 32(2). 308–312. 19 indexed citations
19.
Nuytemans, Karen, Rosa Rademakers, Jessie Theuns, et al.. (2008). Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients. European Journal of Human Genetics. 16(4). 471–479. 38 indexed citations
20.
Bogaerts, Veerle, Karen Nuytemans, Joke Reumers, et al.. (2008). Genetic variability in the mitochondrial serine proteaseHTRA2contributes to risk for Parkinson disease. Human Mutation. 29(6). 832–840. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026